The advent of selective monoamine oxidase A inhibitor antidepressants devoid of the cheese reaction.
Youdim
M B
MB
Technion-Israel Institute of Technology, Faculty of Medicine, Department of Pharmacology, Haifa.
D001549:Benzamides / Q000627:therapeutic use; D002611:Cheese / Q000009:adverse effects*; D003010:Clorgyline / Q000627:therapeutic use; D003866:Depressive Disorder / Q000188:drug therapy*; D006801:Humans; D006973:Hypertension / Q000209:etiology*; D020912:Moclobemide; D008996:Monoamine Oxidase Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use*; D012642:Selegiline / Q000627:therapeutic use; D014439:Tyramine / Q000009:adverse effects
D001549:Benzamides; D008996:Monoamine Oxidase Inhibitors; D012642:Selegiline; D003010:Clorgyline; D020912:Moclobemide; D014439:Tyramine